DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer
Although most prostate cancer (PCa) cases are not life-threatening, approximately 293 000 men worldwide die annually due to PCa. These lethal cases are thought to be caused by coordinated genomic alterations that accumulate over time. Recent genome-wide analyses of DNA from subjects with PCa have re...
Main Author: | Wennuan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Asian Journal of Andrology |
Subjects: | |
Online Access: | http://www.ajandrology.com/article.asp?issn=1008-682X;year=2016;volume=18;issue=4;spage=533;epage=542;aulast=Liu |
Similar Items
-
Genomic alterations in neuroendocrine prostate cancer: A systematic review and meta‐analysis
by: Junru Chen, et al.
Published: (2023-05-01) -
Genome-Based Classification and Therapy of Prostate Cancer
by: Arlou Kristina Angeles, et al.
Published: (2018-09-01) -
Genomic Alteration Burden in Advanced Prostate Cancer and Therapeutic Implications
by: Matthew J. Ryan, et al.
Published: (2019-11-01) -
Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death
by: Haley Hieronymus, et al.
Published: (2018-09-01) -
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
by: Vincenza Conteduca, et al.
Published: (2022-04-01)